Case Report

Late Occurrence of PML in a Patient Treated for Lymphoma with Immunomodulatory Chemotherapies, Bendamustine, Rituximab, and Ibritumomab Tiuxetan

Table 1

Laboratory and diagnostic workup.

TestResult

CSF study 1 (4/18/2014)Cells 3, RBC 0, glucose 75, protein 56, cytology negative, JC virus PCR negative
CSF study 2 (5/9/2014)Cells 6, RBC 3, glucose 70, protein 57, cytology negative, flow cytometry negative, JC virus PCR positive
HIV 1 & 2 Negative
CD4 count144